|
|
Article: Teva Announces Approval of Generic Accupril(R) Tablets.
- Article from:
- Business Wire
- Article date:
- August 27, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
JERUSALEM, Israel -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that, following the expiration of pediatric exclusivity for U.S. Patent No. 4,743,450, the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Pfizer's hypertension treatment Accupril[R] (Quinapril Hydrochloride) Tablets, 5 mg, 10 mg, 20 mg and 40 mg. Shipment of this product will commence shortly.
Total annual sales of Quinapril HCl Tablets in the U.S., including brand and generic sales, were approximately $150 million for the twelve months ended June 30, 2007, based on IMS ...